AU2003210382A8 - Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) - Google Patents

Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)

Info

Publication number
AU2003210382A8
AU2003210382A8 AU2003210382A AU2003210382A AU2003210382A8 AU 2003210382 A8 AU2003210382 A8 AU 2003210382A8 AU 2003210382 A AU2003210382 A AU 2003210382A AU 2003210382 A AU2003210382 A AU 2003210382A AU 2003210382 A8 AU2003210382 A8 AU 2003210382A8
Authority
AU
Australia
Prior art keywords
gpr105
diagnostic
diseases associated
coupled receptor
protein coupled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210382A
Other versions
AU2003210382A1 (en
Inventor
Ulf Bruggemeier
Stefan Golz
Andreas Geerts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003210382A8 publication Critical patent/AU2003210382A8/en
Publication of AU2003210382A1 publication Critical patent/AU2003210382A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003210382A 2002-03-13 2003-02-28 Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) Abandoned AU2003210382A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02005310.4 2002-03-13
EP02005310 2002-03-13
PCT/EP2003/002053 WO2003076945A2 (en) 2002-03-13 2003-02-28 Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)

Publications (2)

Publication Number Publication Date
AU2003210382A8 true AU2003210382A8 (en) 2003-09-22
AU2003210382A1 AU2003210382A1 (en) 2003-09-22

Family

ID=27798780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210382A Abandoned AU2003210382A1 (en) 2002-03-13 2003-02-28 Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)

Country Status (2)

Country Link
AU (1) AU2003210382A1 (en)
WO (1) WO2003076945A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009070873A1 (en) * 2007-12-04 2009-06-11 Merck Frosst Canada Ltd. Substituted 2-naphthoic acids as antagonists of gpr105 activity
AU2014346641B2 (en) 2013-11-07 2018-09-27 The General Hospital Corporation Compositions and methods for detecting and/or treating inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524372A (en) * 1998-05-01 2003-08-19 スミスクライン・ビーチャム・コーポレイション Screening method for agonists and antagonists of the interaction between human KIAA0001 receptor and its ligand
US6773883B2 (en) * 2000-07-31 2004-08-10 The Brigham & Women's Hospital, Inc. Prognostic classification of endometrial cancer

Also Published As

Publication number Publication date
WO2003076945A2 (en) 2003-09-18
WO2003076945A3 (en) 2004-06-03
AU2003210382A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
IL197774A0 (en) Corticotropin releasing factor 2 receptor agonists
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003210382A8 (en) Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)
AU2003273994A8 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003229767A8 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003294206A8 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003276106A8 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003250165A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19)
AU2003246726A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003274005A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6)
AU2003301892A8 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)
AU2003221502A8 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
GB0215389D0 (en) Receptor
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003240736A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 2 (sstr2)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003266238A8 (en) Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1)
AU2003213801A8 (en) Toll-like receptor 11

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase